Trial intelligence / Profile preview

Colestyramine for erythropoietic protoporphyria

2007-002863-28Phase 4Terminated

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
Aug 2007
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, single-arm trial of cholestyramine in erythropoietic protoporphyria (EPP), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Reduction in protoporphyrin levels. Started Aug 2007; status: terminated.

02

Drugs

cholestyramine
03

Conditions

erythropoietic protoporphyria (EPP)

Beyond the preview

Go deeper on 2007-002863-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002863-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call